US 11952429
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 11952429 (Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers) held by PRECISION BIOLOGICS, INC. expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRECISION BIOLOGICS, INC.
- Grant date
- Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61K45/06, A61K47/6859